AliveLongevity
ToolsProtocolStart HereBlogBriefsPricingAbout

Article library · Frameworks

Frameworks

1 evidence reviews in this category. Every piece states what the human data shows, how large the effect is, and when to talk to a clinician instead.

  • February 20, 2026 · 11 min read

    Bryan Johnson Blueprint Protocol Review (2026): What Is Transferable and What Is Not

    An evidence-tiered review of Bryan Johnson's published Blueprint protocol: which components have randomized human outcome data, which rest on surrogate biomarkers, which have none at all, and how to adapt the transferable parts in a 12-week block.

Disclosure: Educational content only. This site does not provide medical diagnosis or treatment. Always discuss supplements, labs, and medication changes with a licensed clinician.

Get the weekly research brief

One evidence review, one protocol, one metric to track. Every Friday, no filler.

No spam, unsubscribe anytime. See our privacy policy.

AliveLongevity

Practical, evidence-first guidance and decision tools for a longer healthspan. Human outcomes over hype.

Use Alive

  • Free Decision Tools
  • Supplement Scorecard
  • Wearable Fit Finder
  • Lab Discussion Builder
  • TRT Cost Calculator
  • PhenoAge Calculator
  • Healthspan Quiz
  • Personalized 90-Day Plan
  • Find a Provider

Explore

  • Longevity Protocol
  • Studio Modality Guide
  • Start Here
  • Article Library
  • Research Briefs
  • Resources
  • Longevity Blueprint
  • About
  • Pricing
  • Provider Partners
  • Partnership Standards
  • Privacy
  • Terms
© 2026 AliveLongevity. Educational content, not medical advice.Sister sites: protocolrank.com and peakedlabs.com